IDS Antikörper (N-Term)

Produktnummer ABIN926632

Produktdetails anti-IDS Antikörper

Target: IDS (Iduronate 2-Sulfatase (IDS))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser IDS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: IDS antibody was raised in rabbit using the N terminal of IDS as the immunogen

Anwendungsinformationen

Applikationshinweise: Optimal conditions should be determined by the investigator.

Kommentare:

IDS Blocking Peptide, catalog no. 33R-8437, is also available for use as a blocking control in assays to test for specificity of this IDS antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu IDS

Target: IDS (Iduronate 2-Sulfatase (IDS))

Andere Bezeichnung: IDS (IDS Produkte)

Synonyme: mps2 antikoerper, sids antikoerper, zgc:158245 antikoerper, MPS2 antikoerper, SIDS antikoerper, AW214631 antikoerper, iduronate 2-sulfatase antikoerper, IDS antikoerper, CpipJ_CPIJ004938 antikoerper, ids antikoerper, Ids antikoerper

Hintergrund: Iduronate-2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to the sex-linked Mucopolysaccharidosis Type II, also known as Hunter Syndrome. Iduronate-2-sulfatase has a strong sequence similarity with human arylsulfatases A, B, and C, and human glucosamine-6-sulfatase. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described. Synonyms: Polyclonal IDS antibody, Anti-IDS antibody, iduronate 2-sulfatase antibody, MPS2 antibody, SIDS antibody.

Pathways: Glycosaminoglycan Metabolic Process